Yayın:
Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure

Küçük Resim

Akademik Birimler

item.page.program

Kurum Yazarları

Yazarlar

DEMİR, MESUT
KANADAŞI, MEHMET
BACAKSIZ, AHMET
Vatankulu, Mehmet Akif
Sahin, Durmus Yildiray
Eker, Rabia Akilli
BOZKURT, ABDİ
Acarturk, Esmeray

Danışman

Tarih

2014-02-01T00:00:00Z

item.page.language

item.page.type

Article

Yayımcı

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Özet

Background: Levosimendan (LS) is a novel inodilator that improves cardiac performance, central hemodynamics, and symptoms of patients with decompensated chronic heart failure. The aim of this study was to compare the effects of single and repeated LS infusion on left ventricular performance, biomarkers, and neurohormonal activation in patients with acute heart failure.

Açıklama

item.page.source

item.page.keywords

Konusu

Alıntı

Tasal A., DEMİR M., KANADAŞI M., BACAKSIZ A., Vatankulu M. A. , Sahin D. Y. , Eker R. A. , BOZKURT A., Acarturk E., -Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure-, MEDICAL SCIENCE MONITOR, cilt.20, 2014

Koleksiyonlar

Endorsement

Review

item.page.supplemented

item.page.referenced

1

Views

12

Downloads

View PlumX Details


İlişkili Sürdürülebilir Kalkınma Hedefleri